Fen‐Fen Lin

1.6k total citations
29 papers, 1.3k citations indexed

About

Fen‐Fen Lin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fen‐Fen Lin has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fen‐Fen Lin's work include Prostate Cancer Treatment and Research (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Ion channel regulation and function (5 papers). Fen‐Fen Lin is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Ion channel regulation and function (5 papers). Fen‐Fen Lin collaborates with scholars based in United States, Japan and Switzerland. Fen‐Fen Lin's co-authors include Michael Webb, Naichen Yu, Tadimeti S. Rao, Ming‐Fong Lin, Karen Lariosa‐Willingham, Chui‐Se Tham, Ming‐Shyue Lee, Jerold Chun, Dev Karan and Tsukasa Igawa and has published in prestigious journals such as Biochemistry, Brain Research and Journal of Neurochemistry.

In The Last Decade

Fen‐Fen Lin

29 papers receiving 1.3k citations

Peers

Fen‐Fen Lin
Joshua Murtie United States
Shelley B. Hooks United States
Anthony L. Gard United States
Hu Zhu United States
Eric Koncina Luxembourg
Rajappa S. Kenchappa United States
Joshua Murtie United States
Fen‐Fen Lin
Citations per year, relative to Fen‐Fen Lin Fen‐Fen Lin (= 1×) peers Joshua Murtie

Countries citing papers authored by Fen‐Fen Lin

Since Specialization
Citations

This map shows the geographic impact of Fen‐Fen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fen‐Fen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fen‐Fen Lin more than expected).

Fields of papers citing papers by Fen‐Fen Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fen‐Fen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fen‐Fen Lin. The network helps show where Fen‐Fen Lin may publish in the future.

Co-authorship network of co-authors of Fen‐Fen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Fen‐Fen Lin. A scholar is included among the top collaborators of Fen‐Fen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fen‐Fen Lin. Fen‐Fen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaida, Kevin, Hossein Salimi-Moosavi, Raju Subramanian, et al.. (2014). Inhibition of CRAC with a human anti-ORAI1 monoclonal antibody inhibits T-cell-derived cytokine production but fails to inhibit a T-cell-dependent antibody response in the cynomolgus monkey. Journal of Immunotoxicology. 12(2). 164–173. 11 indexed citations
2.
Guzman, Roberto E., Eliane G. Valente, Efrain Pacheco, et al.. (2014). Expression of ORAI1, a Plasma Membrane Resident Subunit of the CRAC Channel, in Rodent and Non-rodent Species. Journal of Histochemistry & Cytochemistry. 62(12). 864–878. 18 indexed citations
3.
Lin, Fen‐Fen, Robin Elliott, Anne Colombero, et al.. (2013). Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease. Journal of Pharmacology and Experimental Therapeutics. 345(2). 225–238. 63 indexed citations
4.
Karan, Dev, Sonny L. Johansson, Fen‐Fen Lin, et al.. (2007). Prostate‐derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor‐positive human prostate cancer cells. The Prostate. 67(5). 557–571. 65 indexed citations
5.
Webb, Michael, Chui‐Se Tham, Fen‐Fen Lin, et al.. (2004). Sphingosine 1-phosphate receptor agonists attenuate relapsing–remitting experimental autoimmune encephalitis in SJL mice. Journal of Neuroimmunology. 153(1-2). 108–121. 194 indexed citations
6.
Varney, Mark A., Fen‐Fen Lin, Christine Jachec, et al.. (2003). Stable Expression of Human NMDA Receptors in Cultured Mammalian Cells. Humana Press eBooks. 128. 43–59. 4 indexed citations
7.
Yu, Naichen, Karen Lariosa‐Willingham, Fen‐Fen Lin, Michael Webb, & Tadimeti S. Rao. (2003). Characterization of lysophosphatidic acid and sphingosine‐1‐phosphate‐mediated signal transduction in rat cortical oligodendrocytes. Glia. 45(1). 17–27. 106 indexed citations
8.
9.
Rao, Tadimeti S., Karen Lariosa‐Willingham, Fen‐Fen Lin, et al.. (2003). Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes. Brain Research. 990(1-2). 182–194. 84 indexed citations
10.
Lee, Ming‐Shyue, Dana van Bemmel, Jamie S. Lin, et al.. (2003). p66Shc protein is upregulated by steroid hormones in hormone‐sensitive cancer cells and in primary prostate carcinomas. International Journal of Cancer. 108(5). 672–678. 38 indexed citations
11.
Igawa, Tsukasa, Fen‐Fen Lin, Ming‐Shyue Lee, et al.. (2002). Establishment and characterization of androgen‐independent human prostate cancer LNCaP cell model. The Prostate. 50(4). 222–235. 156 indexed citations
12.
Igawa, Tsukasa, Fen‐Fen Lin, Ming‐Shyue Lee, et al.. (2002). Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. The Prostate. 50(4). 222–222. 5 indexed citations
13.
Lin, Ming‐Fong, et al.. (2001). PROTEIN KINASE C PATHWAY IS INVOLVED IN REGULATING THE SECRETION OF PROSTATIC ACID PHOSPHATASE IN HUMAN PROSTATE CANCER CELLS. Cell Biology International. 25(11). 1139–1148. 5 indexed citations
14.
Lin, Ming‐Fong, Ming‐Shyue Lee, Renee Garcia‐Arenas, & Fen‐Fen Lin. (2000). DIFFERENTIAL RESPONSIVENESS OF PROSTATIC ACID PHOSPHATASE AND PROSTATE‐SPECIFIC ANTIGEN mRNA TO ANDROGEN IN PROSTATE CANCER CELLS. Cell Biology International. 24(10). 681–689. 30 indexed citations
15.
Varney, Mark A., Nicholas D. P. Cosford, Christine Jachec, et al.. (1999). SIB-1757 and SIB-1893: Selective, Noncompetitive Antagonists of Metabotropic Glutamate Receptor Type 5. Journal of Pharmacology and Experimental Therapeutics. 290(1). 170–181. 151 indexed citations
16.
Daggett, Lorrie P., Edwin C. Johnson, Mark A. Varney, et al.. (1998). The Human N‐Methyl‐d‐Aspartate Receptor 2C Subunit: Genomic Analysis, Distribution in Human Brain, and Functional Expression. Journal of Neurochemistry. 71(5). 1953–1968. 22 indexed citations
17.
Varney, Mark A., Sara Rao, Christine Jachec, et al.. (1998). Pharmacological Characterization of the Human Ionotropic Glutamate Receptor Subtype GluR3 Stably Expressed in Mammalian Cells. Journal of Pharmacology and Experimental Therapeutics. 285(1). 358–370. 17 indexed citations
18.
Lin, Fen‐Fen, Mark A. Varney, Aida Sacaan, et al.. (1997). Cloning and stable expression of the mGluR1b subtype of human metabotropic receptors and pharmacological comparison with the mGluR5a subtype. Neuropharmacology. 36(7). 917–931. 42 indexed citations
19.
Lin, Ming‐Fong, Mark H. Kawachi, Fen‐Fen Lin, Michael R. Stallcup, & Steven M. Grunberg. (1995). Growth inhibition of androgen‐insensitive human prostate carcinoma cells by a 19‐norsteroid derivative agent, mifepristone. The Prostate. 26(4). 194–204. 41 indexed citations
20.
Lin, Ming‐Fong, et al.. (1994). The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells. Differentiation. 57(2). 143–149. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026